Rare Disease Trial, Recruiting NCT06474104 Sponsor: Minovia Therapeutics Ltd. Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT06474104
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 3 and 85 years old (male or female)
  • If you have Primary Mitochondrial Disease: You have been diagnosed with this condition confirmed through a specific genetic (DNA) test of your mitochondria
  • If you are a Healthy Volunteer: Your vital signs (such as heart rate and blood pressure) and body weight are normal for your age, you have no active health conditions, and you take no regular medications (except for paracetamol/acetaminophen or naproxen sodium)
  • You have not had a viral or bacterial illness in the past 2 weeks
  • You have not taken any antibiotic or antiviral medications in the past 2 weeks
  • You have not had a blood transfusion in the past 2 weeks
  • You are not currently pregnant or breastfeeding
  • You drink fewer than 2 alcoholic drinks per day
  • You have not used recreational or illegal drugs in the past year
  • You have not used tobacco or any nicotine-containing products in the past year
  • You (or your parent or guardian, if applicable) are able to understand and sign a written consent form voluntarily

Who may not be able to join:

  • You have previously received a stem cell transplant from another person (allogeneic hematopoietic stem cell transplantation)
  • You have previously received gene therapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0586101291

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Minovia Therapeutics Ltd.
Registry
ClinicalTrials.gov
Start date
12 May 2024
Est. completion
30 May 2027

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

mitochondrial function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov